$AEO
AMERICAN EAGLE OUTFITTERS INC

2020 Q2 Form 10-Q Financial Statement

#000156459021031407 Filed on June 02, 2021

View on sec.gov

Income Statement

Concept 2020 Q2
Revenue $551.7M
YoY Change -37.75%
Cost Of Revenue $523.4M
YoY Change -6.77%
Gross Profit $28.31M
YoY Change -91.29%
Gross Profit Margin 5.13%
Selling, General & Admin $188.2M
YoY Change -18.44%
% of Gross Profit 664.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $43.40M
YoY Change -4.3%
% of Gross Profit 153.32%
Operating Expenses $188.2M
YoY Change -18.44%
Operating Profit -$358.2M
YoY Change -848.74%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$3.000M
YoY Change -171.74%
Pretax Income -$361.4M
YoY Change -794.63%
Income Tax -$104.2M
% Of Pretax Income
Net Earnings -$257.2M
YoY Change -731.04%
Net Earnings / Revenue -46.61%
Basic Earnings Per Share -$1.54
Diluted Earnings Per Share -$1.54
COMMON SHARES
Basic Shares Outstanding 166.8M
Diluted Shares Outstanding 166.8M

Balance Sheet

Concept 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $885.7M
YoY Change 153.27%
Cash & Equivalents $855.8M
Short-Term Investments $386.5M
Other Short-Term Assets $144.7M
YoY Change 104.09%
Inventory $421.7M
Prepaid Expenses
Receivables $106.8M
Other Receivables $0.00
Total Short-Term Assets $1.559B
YoY Change 63.99%
LONG-TERM ASSETS
Property, Plant & Equipment $667.3M
YoY Change -10.4%
Goodwill $12.97M
YoY Change -12.5%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $59.20M
YoY Change 57.1%
Total Long-Term Assets $2.071B
YoY Change -10.13%
TOTAL ASSETS
Total Short-Term Assets $1.559B
Total Long-Term Assets $2.071B
Total Assets $3.630B
YoY Change 11.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $177.1M
YoY Change -23.58%
Accrued Expenses $398.5M
YoY Change 17.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $662.2M
YoY Change 1.91%
LONG-TERM LIABILITIES
Long-Term Debt $643.0M
YoY Change
Other Long-Term Liabilities $24.63M
YoY Change -29.9%
Total Long-Term Liabilities $1.971B
YoY Change 44.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $662.2M
Total Long-Term Liabilities $1.971B
Total Liabilities $2.633B
YoY Change 30.77%
SHAREHOLDERS EQUITY
Retained Earnings $1.826B
YoY Change -9.97%
Common Stock $648.8M
YoY Change 13.25%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.423B
YoY Change 7.46%
Treasury Stock Shares $84.07M
Shareholders Equity $997.0M
YoY Change
Total Liabilities & Shareholders Equity $3.630B
YoY Change 11.51%

Cashflow Statement

Concept 2020 Q2
OPERATING ACTIVITIES
Net Income -$257.2M
YoY Change -731.04%
Depreciation, Depletion And Amortization $43.40M
YoY Change -4.3%
Cash From Operating Activities -$209.9M
YoY Change -2819.19%
INVESTING ACTIVITIES
Capital Expenditures $33.91M
YoY Change -7.28%
Acquisitions
YoY Change
Other Investing Activities $191.0K
YoY Change -5.91%
Cash From Investing Activities -$9.057M
YoY Change -187.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $20.00M
YoY Change 0.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 714.6M
YoY Change -1632.13%
NET CHANGE
Cash From Operating Activities -209.9M
Cash From Investing Activities -9.057M
Cash From Financing Activities 714.6M
Net Change In Cash 493.8M
YoY Change -1823.16%
FREE CASH FLOW
Cash From Operating Activities -$209.9M
Capital Expenditures $33.91M
Free Cash Flow -$243.8M
YoY Change 744.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
55343000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y7M6D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y8M12D
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M12D
CY2020Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
2405000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
61451000
CY2020Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
22756000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
642972000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
24633000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
325290000
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
14150000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1126165000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
329718000
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1970901000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
249566000
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
165500000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
2496000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
646350000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-55050000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1826413000
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
84066000
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1423226000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
996983000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3630111000
CY2020Q2 us-gaap Gross Profit
GrossProfit
28306000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
188197000
CY2021Q2 aeo Non Operating Interest Income Expense Net
NonOperatingInterestIncomeExpenseNet
-8506000
CY2020Q2 aeo Non Operating Interest Income Expense Net
NonOperatingInterestIncomeExpenseNet
-146000
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
167257000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166781000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206562000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166781000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2938000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-21882000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2938000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21882000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
98401000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-279044000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1247853000
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
20000000
CY2020Q2 aeo Share Repurchases Related To Employee Stock Based Compensation Awards Value
ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
1430000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
68330000
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
714571000
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
87000
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1781000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1086665000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12553000
CY2021Q2 aeo Share Repurchases Related To Employee Stock Based Compensation Awards Value
ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
10944000
CY2021Q2 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
11810000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
95463000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2938000
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1375
CY2021Q2 us-gaap Dividends Common Stock
DividendsCommonStock
22922000
CY2021Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
381000
CY2020Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
191000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-112187000
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9057000
CY2020Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20000000
CY2021Q2 aeo Payments To Repurchase Common Stock From Employees
PaymentsToRepurchaseCommonStockFromEmployees
10944000
CY2020Q2 aeo Payments To Repurchase Common Stock From Employees
PaymentsToRepurchaseCommonStockFromEmployees
1430000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-133798000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
493839000
CY2020Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
406108000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
95463000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-257162000
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
153617000
CY2021Q2 us-gaap Increase Decrease In Retail Related Inventories
IncreaseDecreaseInRetailRelatedInventories
59770000
CY2020Q2 us-gaap Increase Decrease In Retail Related Inventories
IncreaseDecreaseInRetailRelatedInventories
-18134000
CY2021Q2 aeo Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-77296000
CY2020Q2 aeo Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-106627000
CY2021Q2 aeo Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-106319000
CY2020Q2 aeo Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-20597000
CY2021Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-24657000
CY2020Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
87575000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-25056000
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-109482000
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-54810000
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-21598000
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
13485000
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-38587000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
427000
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-209894000
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36806000
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33910000
CY2021Q2 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
75000000
CY2020Q2 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
14956000
CY2020Q2 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
40000000
CY2020Q2 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
330000000
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12086000
CY2021Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22922000
CY2021Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-345000
CY2020Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-107000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22125000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
850477000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
361930000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
716679000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
855769000
CY2021Q2 aeo Number Of Retail Stores Operated And Licensed Worldwide
NumberOfRetailStoresOperatedAndLicensedWorldwide
1300
CY2021Q2 us-gaap Number Of Stores
NumberOfStores
1000
CY2021Q2 aeo Number Of International Store Locations
NumberOfInternationalStoreLocations
200
CY2021Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q2 us-gaap Fiscal Period
FiscalPeriod
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fiscal Year</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our fiscal year is a 52- or 53-week year that ends on the Saturday nearest to January 31. As used herein, “Fiscal 2021” refers to the 52-week period that will end on January 29, 2022.  “Fiscal 2020” refers to the 52-week period ended January 30, 2021.  “Fiscal 2019” refers to the 52-week period ended February 1, 2020. </p>
CY2021Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, our management reviews its estimates based on currently available information. Changes in facts and circumstances may result in revised estimates.</p>
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2900000
CY2021Q2 aeo Property Plant And Equipment Weighted Average Useful Life
PropertyPlantAndEquipmentWeightedAverageUsefulLife
P7Y1M6D
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q2 aeo Revenue Related To Gift Card Breakage
RevenueRelatedToGiftCardBreakage
2500000
CY2020Q2 aeo Revenue Related To Gift Card Breakage
RevenueRelatedToGiftCardBreakage
1700000
CY2021Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
CY2020Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
84100000
CY2021Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
716679000
CY2021Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
850477000
CY2020Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
855769000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
75000000
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
29956000
CY2021Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
791679000
CY2021Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
850477000
CY2020Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
885725000
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
153600000
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
167257000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166781000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
33798000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5507000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206562000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166781000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
93000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3040000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2279209000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2250974000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2232380000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1651242000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1627166000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1565122000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
627967000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
623808000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
667258000
CY2021Q2 us-gaap Goodwill Gross
GoodwillGross
17591000
CY2021Q1 us-gaap Goodwill Gross
GoodwillGross
17463000
CY2020Q2 us-gaap Goodwill Gross
GoodwillGross
17164000
CY2021Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
4196000
CY2021Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
4196000
CY2020Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
4196000
CY2021Q2 us-gaap Goodwill
Goodwill
13395000
CY2021Q1 us-gaap Goodwill
Goodwill
13267000
CY2020Q2 us-gaap Goodwill
Goodwill
12968000
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
93039000
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
92663000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
71879000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
36738000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
35598000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32874000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
56301000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
57065000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
39005000
CY2021Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
69696000
CY2021Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
70332000
CY2020Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
51973000
CY2020 aeo Accumulated Impairment Loss
AccumulatedImpairmentLoss
1700000
CY2017 aeo Accumulated Impairment Loss
AccumulatedImpairmentLoss
2500000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
329718000
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
325290000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
642972000
CY2021Q2 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
68330000
CY2021Q1 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
68330000
CY2020Q2 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
68330000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
12600000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
9400000
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4100000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2900000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.87
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
449000
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
32.58
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
713000
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
16.39
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3676000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.74
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
65533000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2706000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
16.67
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
34033000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1578000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.88
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
27902000
CY2021Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.62
CY2021Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
21.41
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12100000
CY2021Q2 aeo Employee Service Share Based Compensation Tax Benefit Expense Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitExpenseRealizedFromExerciseOfStockOptions
2400000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.006
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.016
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.060
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.507
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.431
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y4M24D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7600000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.288
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q2 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
600000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1034614000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
551692000
CY2021Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1034614000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
133427000
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
36806000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
551692000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-358240000
CY2020Q2 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
155619000
CY2020Q2 aeo Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
-202621000
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
33910000
CY2021Q2 aeo Non Operating Interest Expense Net
NonOperatingInterestExpenseNet
8500000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1900000
CY2020Q2 aeo Non Operating Interest Expense Net
NonOperatingInterestExpenseNet
100000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000000.0
CY2021Q2 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
153617000
CY2020Q2 us-gaap Restructuring Costs
RestructuringCosts
2002000
CY2020Q2 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
155619000
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
153600000
CY2021Q1 us-gaap Restructuring Reserve
RestructuringReserve
2812000
CY2021Q2 aeo Payments For Restructuring And Restructuring Reserve Accrual Adjustment
PaymentsForRestructuringAndRestructuringReserveAccrualAdjustment
1102000
CY2021Q2 us-gaap Restructuring Reserve
RestructuringReserve
1710000

Files In Submission

Name View Source Status
0001564590-21-031407-index-headers.html Edgar Link pending
0001564590-21-031407-index.html Edgar Link pending
0001564590-21-031407.txt Edgar Link pending
0001564590-21-031407-xbrl.zip Edgar Link pending
aeo-10q_20210501.htm Edgar Link pending
aeo-10q_20210501_htm.xml Edgar Link completed
aeo-20210501.xsd Edgar Link pending
aeo-20210501_cal.xml Edgar Link unprocessable
aeo-20210501_def.xml Edgar Link unprocessable
aeo-20210501_lab.xml Edgar Link unprocessable
aeo-20210501_pre.xml Edgar Link unprocessable
aeo-ex311_9.htm Edgar Link pending
aeo-ex312_7.htm Edgar Link pending
aeo-ex321_6.htm Edgar Link pending
aeo-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending